Bozic Carmen 4

What Happened

• Carmen Bozic, EVP and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), sold 2,329 shares on 2026-02-27 at $480.31 per share, generating proceeds of approximately $1,118,642. The Form 4 lists the transaction as a sale (S), described as an open-market or private sale.

Key Details

• Transaction date and price: 2026-02-27 at $480.31 per share
• Shares sold / proceeds: 2,329 shares for ~$1,118,642
• Filing date / timeliness: Form 4 filed 2026-03-03 for a report period of 2026-02-27 — filing appears timely
• Shares owned after transaction: Not specified in the provided filing
• Footnote: Transaction executed pursuant to a company-approved Rule 10b5-1 trading plan entered 11/20/2025 (preplanned sale)

Context

• Sales under a 10b5-1 plan are prearranged and routine; they do not necessarily signal a change in the insider’s view of the company. For retail investors, purchases typically carry more interpretive weight than routine sales.